Genomics in multiple sclerosis
Authors:
- 30 September 2010
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 112 (7) , 621-624
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006
- Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MSJournal of Neuroimmunology, 2004
- Individual-specific variation of gene expression in peripheral blood leukocytesGenomics, 2004
- Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activityAnnals of Neurology, 2004
- Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic InsultBrain Pathology, 2003
- Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseHuman Molecular Genetics, 2003
- Microarray analysis identifies interferon β-regulated genes in multiple sclerosisJournal of Neuroimmunology, 2003
- Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosisBrain, 2003
- Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genesAnnals of Neurology, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001